Vizient, Inc. (Irving, TX) announced 12 additional drugs have been added to its essential medications list whose absence would threaten hospitals’ ability to provide high quality, timely patient care.
The newly added drugs are:
- acetaminophen
- ammonul
- clobazam
- copper
- erythromycin
- glucarpidase
- ibuprofen
- indomethacin
- levetiracetam
- selenium
- tobramycin
- zinc
Vizient has now designated 211 medications as essential. To compile and update its list, Vizient conducts a comprehensive review of the World Health Organization’s Essential Medicines list, the Advanced Cardiac Life Support and Pediatric Advanced Life Support algorithms as well as gathered direct input of front-line clinicians from Vizient’s member health systems.
Of the 211 drugs designated by Vizient as essential, over 40% are currently included in its private label program, Novaplus.